Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.22% |
| 2 | Technology | 4.92% |
| 3 | Industrials | 4.28% |
| 4 | Consumer Discretionary | 4.13% |
| 5 | Healthcare | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
CALL
IMAX
IMAX
$2.9B
| $1.61M | ﹤0.01% |
72,600
+30,300
| +72% | +$675K |
|
4277
CALL
Fomento Económico Mexicano
FMX
$40.3B
| $1.61M | ﹤0.01% |
18,300
+200
| +1% | +$17.7K |
|
4278
Pebblebrook Hotel Trust
PEB
$2.06B
| $1.61M | ﹤0.01% |
+41,383
| New | +$1.56M |
|
|
ONCE
4279
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.61M | ﹤0.01% |
19,400
-8,100
| -29% | -$625K |
|
|
GES
4280
PUT
DELISTED
Guess Inc
GES
| $1.6M | ﹤0.01% |
75,000
-20,000
| -21% | -$460K |
|
4281
PUT
Watsco Inc
WSO
$12.9B
| $1.6M | ﹤0.01% |
9,000
+2,200
| +32% | +$400K |
|
4282
Unisys
UIS
$209M
| $1.6M | ﹤0.01% |
124,263
-29,470
| -19% | -$353K |
|
4283
First Trust US Equity Opportunities ETF
FPX
$1.57B
| $1.6M | ﹤0.01% |
+22,430
| New | +$1.59M |
|
4284
Precigen
PGEN
$2.18B
| $1.6M | ﹤0.01% |
114,900
+90,020
| +362% | +$1.52M |
|
4285
CALL
RenaissanceRe
RNR
$13.4B
| $1.6M | ﹤0.01% |
13,300
| – | – |
|
4286
PUT
Acadia Pharmaceuticals
ACAD
$4.87B
| $1.6M | ﹤0.01% |
104,700
+29,400
| +39% | +$524K |
|
4287
W.P. Carey
WPC
$16.3B
| $1.6M | ﹤0.01% |
24,597
+17,449
| +244% | +$1.11M |
|
4288
CALL
GDS Holdings
GDS
$6.89B
| $1.6M | ﹤0.01% |
+39,800
| New | +$1.37M |
|
4289
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$549M
| $1.59M | ﹤0.01% |
+30,472
| New | +$1.59M |
|
|
BPT
4290
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $1.59M | ﹤0.01% |
53,300
+14,300
| +37% | +$369K |
|
4291
PUT
Pacira BioSciences
PCRX
$917M
| $1.59M | ﹤0.01% |
49,700
+7,700
| +18% | +$266K |
|
|
DVAX
4292
PUT
DELISTED
Dynavax Technologies
DVAX
| $1.59M | ﹤0.01% |
104,300
-1,200
| -1% | -$20.7K |
|
4293
CALL
ProShares UltraPro Short Dow 30
SDOW
$186M
| $1.59M | ﹤0.01% |
1,327
-598
| -31% | -$702K |
|
4294
PUT
British American Tobacco
BTI
$123B
| $1.59M | ﹤0.01% |
31,500
+13,100
| +71% | +$690K |
|
4295
Greenlight Captial
GLRE
$514M
| $1.59M | ﹤0.01% |
111,888
+25,001
| +29% | +$381K |
|
4296
PUT
Lithia Motors
LAD
$8.3B
| $1.59M | ﹤0.01% |
16,800
-9,600
| -36% | -$951K |
|
|
SPR
4297
CALL
DELISTED
Spirit AeroSystems
SPR
| $1.59M | ﹤0.01% |
18,500
-2,300
| -11% | -$193K |
|
|
NVRO
4298
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.59M | ﹤0.01% |
19,900
+11,000
| +124% | +$912K |
|
4299
PUT
ProShares Short S&P500
SH
$841M
| $1.58M | ﹤0.01% |
13,500
-8,750
| -39% | -$1.03M |
|
|
REN
4300
CALL
DELISTED
Resolute Energy Corporaton
REN
| $1.58M | ﹤0.01% |
50,700
-8,400
| -14% | -$279K |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,571 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,571 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.